ArticleCureus2024
Challenges in the Diagnosis and Management of Renal Cell Carcinoma With Sarcomatoid Differentiation: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research Advances on the Impact of Gut Microbiota on COPD: Exploring New Perspectives on the Microbiota-Gut-Lung Axis.Current microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastatic sarcomatoid renal cell carcinoma (sRCC) is a significant therapeutic and diagnostic challenge due to its rarity and aggressiveness, which contribute to its poor prognosis. This case report presents the case of a 47-year-old Caucasian man with shortness of breath and right-sided abdominal pain. History revealed an extensive smoking history, a left renal mass diagnosed two months ago with inconclusive results, and an enlarged mass on computed tomography (CT) scan one week ago in an emergency department (ED) visit that showed signs consistent with metastatic disease. CT scan on presentation revealed a right posterolateral chest wall mass measuring 8.5×3.5 cm between the 10th and 11th ribs, as well as multiple bilateral pulmonary metastases. CT scan of the head revealed a soft tissue mass anterior to the epiglottis within the vallecula. Left renal pole mass was also consistent with neoplasm, with stable surrounding mass-like densities consistent with adenopathy and involvement of the adrenal gland. Histopathological examination of the 11 cm right chest wall mass biopsy revealed sRCC due to the visualization of spindle to epithelioid tumor with focal clear cell morphology and a prominent vascular network leading to a nested appearance. Management of his symptoms included thoracocentesis of the pleural effusion, nasal cannula due to low partial pressure of oxygen (PO2), pleurodesis, and trending down of the hypercalcemia. Oncology confirmed the spindle cell neoplasm due to stage IV renal cancer; the patient was transferred to hematology-oncology for further evaluation, but soon after succumbed to the complexities of metastatic disease. This case highlights the challenges of the management and diagnosis of metastatic sRCC over a three-week inpatient service, ultimately revealing a poor prognosis due to the aggressiveness and time of diagnosis, emphasizing the need for early detection methods and personalized treatment strategies. Further research is needed to explore novel therapeutic approaches to tackle this rare and aggressive variant of RCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.